Study of AZD9150 and MEDI4736 (Durvalumab) in Japanese Adult Patients With Advanced Solid Malignancies

Trial Identifier:	D5660C00017
Sponsor:	AstraZeneca
NCTID::	NCT03394144
Start Date:	January 2018
Primary Completion Date:	April 2019
Condition:	Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English version
	Japanese translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Japan	Kashiwa, Japan, 277-8577
Japan	Matsuyama-shi, Japan, 791-0280

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.